Gross Profit Trends Compared: Takeda Pharmaceutical Company Limited vs Walgreens Boots Alliance, Inc.

Takeda vs Walgreens: A Decade of Gross Profit Trends

__timestampTakeda Pharmaceutical Company LimitedWalgreens Boots Alliance, Inc.
Wednesday, January 1, 2014125683400000021569000000
Thursday, January 1, 2015127197300000026753000000
Friday, January 1, 2016117329600000029874000000
Sunday, January 1, 2017127461000000029162000000
Monday, January 1, 2018143753400000030792000000
Tuesday, January 1, 2019220142400000028159000000
Wednesday, January 1, 2020220350400000026077000000
Friday, January 1, 2021246216000000028067000000
Saturday, January 1, 2022278340600000028266000000
Sunday, January 1, 2023283225700000027072000000
Monday, January 1, 2024283225700000026524000000
Loading chart...

Unlocking the unknown

Gross Profit Trends: A Tale of Two Giants

In the ever-evolving landscape of global business, Takeda Pharmaceutical Company Limited and Walgreens Boots Alliance, Inc. stand as titans in their respective industries. Over the past decade, Takeda has demonstrated a remarkable growth trajectory, with its gross profit surging by approximately 125% from 2014 to 2024. This Japanese pharmaceutical giant has consistently outperformed, with its gross profit peaking in 2023 and 2024 at around 2.83 trillion yen.

On the other hand, Walgreens Boots Alliance, a leader in the retail pharmacy sector, has shown a more modest growth pattern. From 2014 to 2024, its gross profit increased by about 23%, reaching a high of approximately 30.8 billion dollars in 2018. Despite facing challenges in recent years, Walgreens continues to maintain a steady performance.

These trends highlight the dynamic nature of global markets and the strategic maneuvers companies must undertake to thrive.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025